» OVAIRE ADENOCARCINOME

ADENOCARCINOME



Généralités des carcinomes ovariens (type et grade)
Imagerie : #1, #2
Carcinomes psammomateux : (

Les carcinomes séreux

Carcinomes mucineux

Adénocarcinome endométrioïde

Les adénocarcinomes adénocarcinomes


(14) Seidman JD, Russell P, Kurman RJ. Surface epithelium tumors of the ovary. In : Kurman RJ, editor. Blausteins's Pathology of the female genital tract. New-York : Springer Verlag, 2001 : 781-904.

(23) Scully RE, Sobin LH. Histological typing of ovarian tumours. second ed. Berlin : Springer verlag, 1999.

(32) Scully RE. Tumors of the ovary and maldeveloped gonads. second series ed. Washington : Armed forces institute of pathology, 1978.

(63) Gilks CB, Bell DA, Scully RE. Serous psammocarcinoma of the ovary and peritoneum. Int J Gynecol Pathol 1990 ; 9(2):110-121.

(64) Keen CE, Szakacs S, Okon E, Rubin JS, Bryant BM. CA125 and thyroglobulin staining in papillary carcinomas of thyroid and ovarian origin is not completely specific for site of origin. Histopathology 1999 ; 34(2):113-117.

(65) Fujimura M, Hidaka T, Kataoka K, Yamakawa Y, Akada S, Teranishi A et al. Absence of estrogen receptor-alpha expression in human ovarian clear cell adenocarcinoma compared with ovarian serous, endometrioid, and mucinous adenocarcinoma. Am J Surg Pathol 2001 ; 25(5):667-672.

(66) Goldstein NS, Uzieblo A. WT1 immunoreactivity in uterine papillary serous carcinomas is different from ovarian serous carcinomas. Am J Clin Pathol 2002 ; 117(4):541-545.

(67) Hecht JL, Lee BH, Pinkus JL, Pinkus GS. The value of Wilms tumor susceptibility gene 1 in cytologic preparations as a marker for malignant mesothelioma. Cancer 2002 ; 96(2):105-109.

(68) Choi YL, Kim HS, Ahn G. Immunoexpression of inhibin alpha subunit, inhibin/activin betaA subunit and CD99 in ovarian tumors. Arch Pathol Lab Med 2000 ; 124(4):563-569.

(69) Aure JC, Hoeg K, Kolstad P. Clinical and histologic studies of ovarian carcinoma. Long-term follow-up of 990 cases. Obstet Gynecol 1971 ; 37(1):1-9.

(70) Sorbe B, Frankendal B, Veress B. Importance of histologic grading in the prognosis of epithelial ovarian carcinoma. Obstet Gynecol 1982 ; 59(5):576-582.

(71) Ozols RF, Garvin AJ, Costa J, Simon RM, Young RC. Advanced ovarian cancer : correlation of histologic grade with response to therapy and survival. Cancer 1980 ; 45(3):572-581.

(72) Jacobs AJ, Deligdisch L, Deppe G, Cohen CJ. Histologic correlates of virulence in ovarian adenocarcinoma. I. Effect of differentiation. Am J Obstet Gynecol 1982 ; 143(5):574-580.

(73) Hart WR, Norris HJ. Borderline and malignant mucinous tumors of the ovary. Histologic criteria and clinical behavior. Cancer 1973 ; 31(5):1031-1045.

(75) Hoerl HD, Hart WR. Primary ovarian mucinous cystadenocarcinomas : a clinicopathologic study of 49 cases with long-term follow-up. Am J Surg Pathol 1998 ; 22(12):1449-1462.

(77) Lee KR, Scully RE. Mucinous tumors of the ovary : a clinicopathologic study of 196 borderline tumors (of intestinal type) and carcinomas, including an evaluation of 11 cases with 'pseudomyxoma peritonei'. Am J Surg Pathol 2000 ; 24(11):1447-1464.

(79) Riopel MA, Ronnett BM, Kurman RJ. Evaluation of diagnostic criteria and behavior of ovarian intestinal-type mucinous tumors : atypical proliferative (borderline) tumors and intraepithelial, microinvasive, invasive, and metastatic carcinomas. Am J Surg Pathol 1999 ; 23(6):617-635.

(93) Bague S, Rodriguez IM, Prat J. Sarcoma-like mural nodules in mucinous cystic tumors of the ovary revisited : a clinicopathologic analysis of 10 additional cases. Am J Surg Pathol 2002 ; 26(11):1467-1476.

(94) Baergen RN, Rutgers JL. Mural nodules in common epithelial tumors of the ovary. Int J Gynecol Pathol 1994 ; 13(1):62-72.

(95) Rodriguez IM, Prat J. Mucinous tumors of the ovary : a clinicopathologic analysis of 75 borderline tumors (of intestinal type) and carcinomas. Am J Surg Pathol 2002 ; 26(2):139-152.

(96) Young RH, Scully RE. Mucinous ovarian tumors associated with mucinous adenocarcinomas of the cervix. A clinicopathological analysis of 16 cases. Int J Gynecol Pathol 1988 ; 7(2):99-111.

(97) Roth LM, Czernobilsky B, LANGLEY FA. Ovarian endometrioid adenofibromatous and cystadenofibromatous tumors : benign, proliferating, and malignant. Cancer 1981 ; 48(8):1838-1845.

(101) Roth LM, Liban E, Czernobilsky B. Ovarian endometrioid tumors mimicking Sertoli and Sertoli-Leydig cell tumors : Sertoliform variant of endometrioid carcinoma. Cancer 1982 ; 50(7):1322-1331.

(102) Young RH, Prat J, Scully RE. Ovarian endometrioid carcinomas resembling sex cord-stromal tumors. A clinicopathological analysis of 13 cases. Am J Surg Pathol 1982 ; 6(6):513-522.

(103) Tornos C, Silva EG, Ordonez NG, Gershenson DM, Young RH, Scully RE. Endometrioid carcinoma of the ovary with a prominent spindle-cell component, a source of diagnostic confusion. A report of 14 cases. Am J Surg Pathol 1995 ; 19(12):1343-1353.

(104) Nogales FF, Bergeron C, Carvia RE, Alvaro T, Fulwood HR. Ovarian endometrioid tumors with yolk sac tumor component, an unusual form of ovarian neoplasm. Analysis of six cases. Am J Surg Pathol 1996 ; 20(9):1056-1066.

(105) Ulbright TM, Roth LM. Metastatic and independent cancers of the endometrium and ovary : a clinicopathologic study of 34 cases. Hum Pathol 1985 ; 16(1):28-34.

(106) Russell P, Bannatyne PM, Solomon HJ, Stoddard LD, Tattersall MH. Multifocal tumorigenesis in the upper female genital tract—implications for staging and management. Int J Gynecol Pathol 1985 ; 4(3):192-210.

(107) Woodruff JD, Solomon D, Sullivant H. Multifocal disease in the upper genital canal. Obstet Gynecol 1985 ; 65(5):695-698.

(108) Eifel P, Hendrickson M, Ross J, Ballon S, Martinez A, Kempson R. Simultaneous presentation of carcinoma involving the ovary and the uterine corpus. Cancer 1982 ; 50(1):163-170.

(109) Fujii H, Matsumoto T, Yoshida M, Furugen Y, Takagaki T, Iwabuchi K et al. Genetics of synchronous uterine and ovarian endometrioid carcinoma : combined analyses of loss of heterozygosity, PTEN mutation, and microsatellite instability. Hum Pathol 2002 ; 33(4):421-428.

(110) Prat J. Clonality analysis in synchronous tumors of the female genital tract. Hum Pathol 2002 ; 33(4):383-385.

(111) Lyon M. Gene action in the Xchromosome of the mouse. Nature 1961 ; 190:372-373.

(112) Fu YS, Stock RJ, Reagan JW, Storaasli JP, Wentz WB. Significance of squamous components in endometrioid carcinoma of the ovary. Cancer 1979 ; 44(2):614-621.

(113) Roth LM, LANGLEY FA, Fox H, Wheeler JE, Czernobilsky B. Ovarian clear cell adenofibromatous tumors. Benign, of low malignant potential, and associated with invasive clear cell carcinoma. Cancer 1984 ; 53(5):1156-1163.

(114) Young RH, Scully RE. Oxyphilic clear cell carcinoma of the ovary. A report of nine cases. Am J Surg Pathol 1987 ; 11(9):661-667.

(115) Zirker TA, Silva EG, Morris M, Ordonez NG. Immunohistochemical differentiation of clear-cell carcinoma of the female genital tract and endodermal sinus tumor with the use of alpha-fetoprotein and Leu-M1. Am J Clin Pathol 1989 ; 91(5):511-514.



Documents de pathologie humaine du service d’anatomie pathologique du CFB de Caen et du CHPC de Cherbourg. L ’UTILISATION DES INFORMATIONS FOURNIES SE FAIT SOUS L’UNIQUE RESPONSABILITE DE L’UTILISATEUR. Les concepteurs et réalisateurs de cette base ne sauraient en aucun cas être tenus pour responsables des conséquences d’une utilisation non contrôlée des informations fournies.

Performed by Arnaud Legrand 2009 © All Rights Reserved.